Background Screening programs involve testing asymptomatic individuals with an accurate
screening test to identify those likely to have the disease of interest and to further investigate …

Human papillomavirus (HPV) vaccination prevents cervical, head and neck, and anogenital
cancers. However, global HPV vaccine coverage falls short of global targets and has seen …

Human papillomavirus (HPV)-related screening technologies and HPV vaccination offer
enormous potential for cancer prevention, notably prevention of cervical cancer. The …

In 2008, a national human papillomavirus (HPV) immunization program using a bivalent
vaccine against HPV types 16 and 18 was implemented in Scotland along with a national …

METHODS: Data were derived from the National Immunization Survey-Teen, spanning 2008–
2018. Using health care provider–verified vaccination histories, we examined trends in …

We currently have the knowledge and experience to prevent much of human papillomavirus
(HPV)-related disease burden globally. In many countries where prophylactic HPV …

We report final event-driven analysis data on the immunogenicity and efficacy of the human
papillomavirus 16 and 18 ((HPV-16/18) AS04-adjuvanted vaccine in young women aged 15 …

In 2018, WHO called for global action to eliminate cervical cancer. The complexity of the
processes involved in terms of prevention is often underestimated. Low‐and middle‐income …

Human papillomavirus (HPV) is implicated in over 90% of cervical cancer cases, with factors
like regional variability, HPV genotype, the population studied, HPV vaccination status, and …

Gonorrhea, one of the most common sexually transmitted infections worldwide, can lead to
serious sequelae, including infertility and increased HIV transmission. Recently, untreatable …